These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
303 related items for PubMed ID: 4540328
1. [The treatment of inherited coagulation disorders]. Blombäck M, Nilsson IM. Lakartidningen; 1972 Dec 27; 69():Suppl 4:76-84. PubMed ID: 4540328 [No Abstract] [Full Text] [Related]
2. Surgical care of patients with hereditary disorders of blood coagulation. Shulman NR. Mod Treat; 1968 Jan 27; 5(1):61-83. PubMed ID: 4870180 [No Abstract] [Full Text] [Related]
3. Surgery in haemophilic patients with inhibitors. Rodriguez-Merchan EC. Haemophilia; 2004 Sep 27; 10 Suppl 2():1-2. PubMed ID: 15385039 [No Abstract] [Full Text] [Related]
4. [Substitution therapy of hemorrhagic diseases]. Haupt H. Anasthesiol Intensivmed Prax; 1975 Oct 27; 11(1):137-44. PubMed ID: 1225069 [No Abstract] [Full Text] [Related]
5. Blood and neoplastic diseases. Haemophilia and related disorders. Rizza CR. Br Med J; 1974 Oct 05; 4(5935):36-8. PubMed ID: 4547674 [No Abstract] [Full Text] [Related]
6. Progress in the clinical management of haemophilia. Bloom AL. Thromb Haemost; 1991 Jul 12; 66(1):166-77. PubMed ID: 1926047 [No Abstract] [Full Text] [Related]
7. Treatment of hemophilia B with a new clotting-factor concentrate. Hoag MS, Johnson FF, Robinson JA, Aggeler PM. N Engl J Med; 1969 Mar 13; 280(11):581-6. PubMed ID: 5764825 [No Abstract] [Full Text] [Related]
8. Drug therapy reviews: clinical use of hemostatic agents. Lowe GD, Lawson DH. Am J Hosp Pharm; 1978 Apr 13; 35(4):414-22. PubMed ID: 306196 [Abstract] [Full Text] [Related]
9. Medical staff conference: Hemophilia and von Willebrand's disease. Fourth annual Paul M. Aggeler memorial lecture. West J Med; 1974 Mar 13; 120(3):226-32. PubMed ID: 4544608 [No Abstract] [Full Text] [Related]
10. Pioneering designs for recombinant coagulation factors. Schulte S. Thromb Res; 2011 Mar 13; 128 Suppl 1():S9-12. PubMed ID: 22221848 [Abstract] [Full Text] [Related]
11. Hereditary disorders of blood coagulation. Zieve PD, Levin J. Major Probl Intern Med; 1976 Mar 13; 10():51-64. PubMed ID: 785116 [No Abstract] [Full Text] [Related]
12. [Capacity of activation of so-called deficient factors in hereditary blood coagulation disorders]. Mingers AM. Fortschr Med; 1976 Oct 21; 94(30):1723-5. PubMed ID: 1086815 [Abstract] [Full Text] [Related]
13. [Reflections on the use of PPSB fraction (Prothrombin-proconvertin-Stuart factor-antihemophilic factor B)]. Malinvaud G. Transfusion (Paris); 1966 Oct 21; 9(3):245-54. PubMed ID: 5969560 [No Abstract] [Full Text] [Related]
14. Editorial: Factor VIII inhibitors. Deykin D. N Engl J Med; 1974 Jul 25; 291(4):205. PubMed ID: 4834491 [No Abstract] [Full Text] [Related]
15. Clinical uses of plasma and plasma fractions: plasma-derived products for hemophilias A and B, and for von Willebrand disease. Josephson CD, Abshire TC. Best Pract Res Clin Haematol; 2006 Jul 25; 19(1):35-49. PubMed ID: 16377540 [Abstract] [Full Text] [Related]
16. Comprehensive care for hemophilia and other inherited bleeding disorders. Page D. Transfus Apher Sci; 2019 Oct 25; 58(5):565-568. PubMed ID: 31427262 [Abstract] [Full Text] [Related]